Table 1.
Demographic and Clinical Variables | Severe Asthmatics | Non-Severe Asthmatics | Normal Controls |
---|---|---|---|
Number of study subjects | 60 | 34 | 26 |
Categorical Variables | Number (Percent) | Number (Percent) | Number (Percent) |
Female gender | 33 (55.0%) | 20 (58.8%) | 17 (65.4%) |
Percent of Lung Less than −850 HU above median | 37 (61.7%) | 14 (41.2%) | 9 (34.6%) |
Atopic | 46 (76.7%) | 31(91.2%) | 8 (30.8%) |
Current Use of Oral Steroids | 26 (43.3%) | 0 (0%) | 0 (0%) |
Current Use of Inhaled Steroids | 59 (98.3%) | 18 (52.9%) | 0 (0%) |
Continuous Variables | Mean (Standard Deviation) | Mean (Standard Deviation) | Mean (Standard Deviation) |
Age | 37.5 (13.3) | 34.3 (10.7) | 30.3 (7.8) |
Percent less −850 | 20.2 (16.7) | 12.1 (12.0) | 12.3 (16.7) |
FEV1 percent predicted | 62.7 (22.1) | 79.7 (16.6) | 99.7 (10.0) |
FEV1/FVC (× 100) | 62.6 (13.0) | 70.1 (11.6) | 84.9 (6.3) |
IgE level | 441.6 (694.8) | 229.7 (295.0) | 93.5 (171.5) |